Finncure

Synthetic carrier particles for targeted drug delivery, developed for pharma and biotech partners in Finland

Espoo, FinlandFounded 2021finncure.fiWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-31

About Finncure

Finncure develops functionalized carrier particles that bind to target receptors to deliver therapeutic compounds precisely, and can also block receptors to prevent pathogen entry into cells. Current development centres on lipid nanoparticles, though the platform is not limited to lipid-based systems.

Its customers are pharmaceutical and biotech companies, which it works with to integrate their therapeutic compounds into the carrier platform. The company describes its model as collaboration, development and licensing partnerships.

Finncure Oy was founded in 2021 and is headquartered in Espoo, Finland. Preclinical studies were conducted at Charles River Laboratories and Tebubio.

Product: Receptor-targeted synthetic carrier particles for delivering therapeutic compounds

Jobs at Finncure

No open positions listed right now.

Leadership

More biotech & pharma companies

  • FinVector

    CGMP manufacturer of viral-based gene therapy products in Kuopio, Finland, for pharmaceutical partners
    Kuopio, FinlandBiotech & pharmaFounded 19933 open jobs
    New on Evolc
  • Galena Pharma

    Contract manufacturer of CE-marked medical devices and OTC health products sold as white-label for pharma and healthcare companies
    Kuopio, FinlandBiotech & pharmaFounded 19961 open job
    New on Evolc
  • Gencyst

    Supplies antibodies, ELISA kits and lab reagents to research labs and runs bioequivalence studies for pharma developers
    Helsinki, FinlandBiotech & pharmaFounded 20228 open jobs
    Young companyNew on Evolc
  • Genevia Technologies

    Bioinformatics analysis services for life science researchers and biotech companies, sold per project or as retained expert support
    Tampere, FinlandBiotech & pharmaFounded 20111 open job
    New on EvolcRemote-friendly
  • GlucoModicum

    Non-invasive, needle-free glucose monitoring for people with diabetes, based on magnetohydrodynamic technology
    Helsinki, FinlandBiotech & pharmaFounded 2018
    New on Evolc
  • Glykos Finland

    Develops antibody-drug conjugates and glycan analysis services for pharmaceutical companies and research institutions
    Helsinki, FinlandBiotech & pharmaFounded 2004
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Google reCAPTCHA
  • PHP
  • nginx